QIAGEN launches QIAseq Human Exome TR Insights, a new integrated solution for Whole Exome Sequencing

Hilden, Germany, and Germantown, Maryland, October 28, 2020 – QIAGEN today announced the launch of QIAseq Human Exome TR Insights, an innovative solution combining high-performance chemistry with robust bioinformatics to enable customers to sequence and analyze multiple types of genomic variation across the entire human exome. This integrated research solution offers rapid preparation of next-generation... Read more

Brooks Automation Announces Fiscal 2020 Fourth Quarter and Year-End Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2020 Fourth Quarter and Year-End Earnings Conference Call and Webcast CHELMSFORD, Mass., Oct. 27, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2020 fourth quarter and year-end earnings which ended on September 30, 2020 on Tuesday, November 10, 2020 after the market closes. The Company will host a conference... Read more

Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings

Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings End-to-end solution accelerates clinical trials with speed, convenience and quality WALTHAM, Mass., Oct. 27, 2020 /PRNewswire/ — A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates. The comprehensive offering now includes... Read more

Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics

SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a research collaboration focused on the investigation of clinically relevant molecular targets for use in... Read more

Bio-Techne Announces Commercial Release of New SARS-CoV-2 Multi-antigen Serology Assay Kit for Simple Western

New serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens MINNEAPOLIS, Oct. 19, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for Jess and Wes Simple Western automated western blotting systems.  The SARS-CoV-2 multi-antigen... Read more

PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020. The strong revenue growth performance was driven by continued better-than-expected demand for PerkinElmer’s... Read more

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– The table in the release was incorrect. The corrected table should read: PerkinElmer, Inc: PerkinElmer, Inc. and SubsidiariesRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)     PKI Three Months Ended October 4, 2020 Organic revenue growth: Reported revenue growth 35% Less: effect of foreign exchange rates 1% Less: effect... Read more

Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities

Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Noninvasive, Saliva-Based SARS-CoV-2 Tests for Higher Education Institutions High-Throughput, Integrated Testing Platform and Reliable Supply Chain SOUTH SAN FRANCISCO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a program to expand availability of Fluidigm® COVID-19 tests for U.S. colleges and universities. The Fluidigm COVID-19 Campus Safeguard Program will provide... Read more